Found: 13
Select item for more details and to access through your institution.
Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 2, p. 727, doi. 10.1007/s10072-023-07064-5
- By:
- Publication type:
- Article
Quality of life of adult cancer survivors enrolled in Humanitas Research Hospital's survivorship care model.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 7, p. 5561, doi. 10.1007/s00520-022-06885-y
- By:
- Publication type:
- Article
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 10, p. 2547, doi. 10.1007/s00277-021-04604-x
- By:
- Publication type:
- Article
Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 4, p. 322, doi. 10.1111/j.1600-0609.2007.00814.x
- By:
- Publication type:
- Article
CD34<sup>+</sup> dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 2, p. 111, doi. 10.1111/j.1600-0609.2006.00793.x
- By:
- Publication type:
- Article
Acute megakaryocytic leukemia in essential thrombocythemia: an unusual evolution?
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 2, p. 108, doi. 10.1034/j.1600-0609.2002.02734.x
- By:
- Publication type:
- Article
Efficacy and Feasibility of DA-EPOCH-R in Aggressive B-Cell Lymphoma: A Real Life Single-Center Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S250, doi. 10.1016/j.clml.2019.07.156
- By:
- Publication type:
- Article
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S234, doi. 10.1016/j.clml.2018.07.116
- By:
- Publication type:
- Article
Long-lasting complete clinical remission of multiply relapsing idiopathic multicentric Castleman disease with siltuximab therapy.
- Published in:
- Current Therapeutics, 2022, v. 25, n. 5, p. 24
- By:
- Publication type:
- Article
Tandem high?dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 2, p. 122, doi. 10.1002/ajh.20790
- By:
- Publication type:
- Article
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 369, doi. 10.1111/j.1365-2141.2009.07645.x
- By:
- Publication type:
- Article
Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 323, doi. 10.1634/theoncologist.2014-0420
- By:
- Publication type:
- Article
Acute promyelocytic leukemia with a cryptic insertion of RARA into PML on chromosome 15 due to uniparental isodisomy: A case report.
- Published in:
- 2017
- By:
- Publication type:
- Case Study